WCA
IMMU

Windsor Creek Advisors’s Immunomedics Inc IMMU Stock Holding History

Windsor Creek Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,000
Closed -$40K – 218
2020
Q1 		$40K Buy
+3,000
New +$50.5K 0.01% 164

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Windsor Creek Advisors's IMMU Position: Q2 2020 in Review

Windsor Creek Advisors sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 3,000 shares — an estimated $40K sold.

Windsor Creek Advisors first reported a position in IMMU in Q1 2020 and held it in 1 quarter. The position peaked at $40K in Q1 2020. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

  • Windsor Creek Advisors reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
  • Windsor Creek Advisors sold 3,000 Immunomedics Inc shares in Q2 2020, an estimated $40K.
  • Windsor Creek Advisors first reported a position in Immunomedics Inc in Q1 2020 and held it in 1 quarter.
  • Windsor Creek Advisors's Immunomedics Inc position peaked at $40K in Q1 2020.
  • 313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Windsor Creek Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.